{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-039516","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2023-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.436467+00:00","generated_at":"2026-06-08T19:10:55.235851+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nephros appoints Judy Krandel as CFO; Andrew Astor resigns effective Nov 1, 2023","bullets":["Judy Krandel appointed CFO effective Nov 1, 2023, replacing Andrew Astor.","Krandel receives base salary $140k, 25% bonus target, and inducement option for 122,524 shares at $1.71.","Option vests 25% on first anniversary, then quarterly over 4 years.","Astor remains through Dec 31, 2023 to assist transition."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-039516","json":"https://secwatch.observer/filing/0001493152-23-039516.json","markdown":"https://secwatch.observer/filing/0001493152-23-039516.md","text":"https://secwatch.observer/filing/0001493152-23-039516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223039516/0001493152-23-039516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223039516/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T19:10:55.235851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6dec5a1566","claim":"Judy Krandel was appointed as Chief Financial Officer at NEPHROS INC.","evidence_excerpt":"Nephros, Inc. (the “Company”) appointed Judy Krandel as its Chief Financial Officer, effective November 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223039516/0001493152-23-039516-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"c7b9d2fdb8","claim":"Andrew Astor resigned as Chief Financial Officer at NEPHROS INC.","evidence_excerpt":"On November 1, 2023, in connection with Ms. Krandel’s appointment as Chief Financial Officer, Andrew Astor resigned as the Company’s Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223039516/0001493152-23-039516-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}